# Allogeneic Transplantation For Severe Osteopetrosis

> **NCT00775931** · PHASE2,PHASE3 · COMPLETED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 7 (actual)

## Conditions studied

- Severe Osteopetrosis

## Interventions

- **PROCEDURE:** umbilical cord blood transplantation
- **DRUG:** Campath-1H
- **RADIATION:** Total Lymphoid Irradiation
- **DRUG:** Cyclophosphamide
- **DRUG:** Busulfan
- **DRUG:** Fludarabine monophosphate
- **PROCEDURE:** marrow graft transplantation

## Key facts

- **NCT ID:** NCT00775931
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2019-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00775931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00775931, "Allogeneic Transplantation For Severe Osteopetrosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00775931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*